Solasia Pharma KK's market cap is currently €53.38M. The company's EPS TTM is €-0.006972; its P/E ratio is ―; Solasia Pharma KK is scheduled to report earnings on August 13, 2025, and the estimated EPS forecast is €―. See an overview of income statement, balance sheet, and cash flow financials.
